Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024
View
Cirrhosis & Complications
4
Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024
View
Cirrhosis & Complications
4
Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024
View
Cirrhosis & Complications
4
Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
1
Sobi: When Platelet Count Matters: Prophylaxis Ahead of Procedures in Chronic Liver Disease Patients (CLD) - ILC 2021
View
Cirrhosis & Complications
4
Shionogi: Raising platelets – the growing evidence supporting the use of TPO-RAs for addressing severe thrombocytopenia prior to invasive procedures in patients with chronic liver disease - ILC 2021
View
Cirrhosis & Complications
4
Shionogi: Raising platelets – the growing evidence supporting the use of TPO-RAs for addressing severe thrombocytopenia prior to invasive procedures in patients with chronic liver disease - ILC 2021
